Nick Orr

No ORCID on file · 2 papers in corpus

review 2016

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Gynecologic Oncology ·doi:10.1016/j.ygyno.2015.04.034

OBJECTIVE: Clinical genetic testing is commercially available for rs61764370, an inherited variant residing in a KRAS 3' UTR microRNA binding site, based on suggested associations with increased ovarian and breast cancer risk as well as wit…

meta-analysis 2015

Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma

Nature genetics ·doi:10.1038/ng.3373

Thirteen common susceptibility loci have been reproducibly associated with cutaneous malignant melanoma (CMM). We report the results of an international 2-stage meta-analysis of CMM genome-wide association studies (GWAS). This meta-analysis…